According to the Centers for Disease Control and Prevention, approximately 3 to 7 percent of school-age children are afflicted with attention-deficit hyperactivity disorder (ADHD). ADHD is a disorder characterized by distractibility, impulsivity and hyperactivity that greatly impacts the day-to-day functioning of an individual. There is debate and ongoing research into the causes of ADHD, but biological factors such as abnormal neurotransmitter activity are believed to contribute to the disorder. Therefore, medications, such as atomoxetine (Strattera), to control brain activity are useful to treat the symptoms of ADHD in combination with behavioral therapy.
Indications
Atomoxetine (Strattera) is a prescription medication indicated for the treatment of ADHD in children over 6 years of age and adults. The drug is a selective norepinephrine reuptake inhibitor which works in the brain to increase the amount of available norepinephrine and epinephrine, which are neurotransmitters important in attention as well as many other bodily functions. Atomoxetine affects the body by increasing attention while decreasing impulsiveness and hyperactivity, the hallmarks of ADHD. It is recommended as a part of a total treatment plan for ADHD.
Benefits
Atomoxetine is not a stimulant medication like most ADHD medications. The actions of atomoxetine can be helpful in relieving the symptoms of ADHD, allowing for a better and more focused life. Atomoxetine increases attention and concentration, allowing an individual to be less distracted, better organized and less forgetful, according to Eli Lilly.
Dosage and Administration
Atomoxetine should be taken exactly as prescribed and is available in a variety of dose strengths. The drug is only available in capsule form to be administered orally, with or without food, either once or twice a day. The capsule should never be crushed, chewed or broken open to be mixed with food or liquids.
Side Effects
There are several common side effects for both children and adults taking atomoxetine. These include nausea, decreased appetite and dizziness. Children and teenagers may also experience an upset stomach, lethargy, mood swings and a slowing of growth in both height and weight. Talk to a physician if growth retardation is occurring in a child taking atomoxetine. Adults may also experience constipation, dry mouth, sexual side effects, insomnia, menstrual cramps and problems passing urine.
Warning
The FDA warns of several reported adverse effects in individuals taking atomoxetine. These include a higher chance of suicidal thoughts and actions in children and teenagers, severe liver damage, heart-related problems and new mental illnesses. According to Eli Lilly, four out of every 1,000 individuals taking atomoxetine in a clinical trial developed suicidal thoughts. Atomoxetine does run the risk of causing severe liver injury as well as sudden death, stroke, heart attack, increased heart rate and blood pressure in individuals with heart problems or defects. Atomoxetine should not be taken if an individual is currently taking a MAOI (monoamine oxidase inhibitor), has glaucoma or is allergic to any ingredients in the drug.
